ProHNPs are specific markers of normal myelopoiesis

Blood Cancer Journal

Volumn 4, Issue 3, 2014, Pages

  Emmertsen, F ^a   Glenthoj A ^a   Sonderskov J ^a   Kampmann, P ^a   Sengelov H ^a   Borregaard, N ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA DEFENSIN; BIOLOGICAL MARKER; BUSULFAN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; LYSOZYME; MELPHALAN; METHOTREXATE; MITOXANTRONE; MYELOPEROXIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PRO HUMAN NEUTROPHIL PEPTIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; UNCLASSIFIED DRUG; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOTRANSPLANTATION; APLASTIC ANEMIA; AUTOTRANSPLANTATION; CD34 SELECTION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INDUCTION CHEMOTHERAPY; LARGE CELL LYMPHOMA; MALE; MYELODYSPLASTIC SYNDROME; MYELOPOIESIS; NEUTROPHIL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; REVIEW;

EID: 84901831294     PISSN: None     EISSN: 20445385     Source Type: Journal    
DOI: 10.1038/bcj.2014.11     Document Type: Review

References (33)

1. Mary JY. Normal human granulopoiesis revisited. II. Bone marrow data. Biomed Pharmacother 1985; 39: 66-77.
2. Bainton DF, Ullyot JL, Farquhar MG. The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. J Exp Med 1971; 134: 907-934.
3. Rice WG, Ganz T, Kinkade JM, Selsted ME, Lehrer RI, Parmley RT. Defensin-rich dense granules of human neutrophils. Blood 1987; 70: 757-765.
4. Ganz T, Selsted ME, Szklarek D, Harwig SS, Daher K, Bainton DF et al. Defensins. Natural peptide antibiotics of human neutrophils. J Clin Invest 1985; 76: 1427-1435.
5. Zhang Y, Lu W, Hong M. The membrane-bound structure and topology of a human a-defensin indicate a dimer pore mechanism for membrane disruption. Biochemistry 2010; 49: 9770-9782.
6. Biragyn A. Defensins-non-antibiotic use for vaccine development. Curr Protein Pept Sci 2005; 6: 53-60.
7. Lehrer RI. Multispecific myeloid defensins. Curr Opin Hematol 2007; 14: 16-21.
8. Khanna-Gupta A, Zibello T, Sun H, Gaines P, Berliner N. Chromatin immunoprecipitation (ChIP) studies indicate a role for CCAAT enhancer binding proteins alpha and epsilon (C/EBP alpha and C/EBP epsilon) and CDP/cut in myeloid maturation-induced lactoferrin gene expression. Blood 2003; 101: 3460-3468.
9. Valore EV, Ganz T. Posttranslational processing of defensins in immature human myeloid cells. Blood 1992; 79: 1538-1544.
10. Glenthøj A, Cowland JB, Heegaard NH, Larsen MT, Borregaard N. Serglycin participates in retention of a-defensin in granules during myelopoiesis. Blood 2011; 118: 4440-4448.
11. Arnljots K, Sørensen O, Lollike K, Borregaard N. Timing, targeting and sorting of azurophil granule proteins in human myeloid cells. Leukemia 1998; 12: 1789-1795.
12. Faurschou M, Kamp S, Cowland JB, Udby L, Johnsen AH, Calafat J et al. Prodefensins are matrix proteins of specific granules in human neutrophils. J Leukoc Biol 2005; 78: 785-793.
13. Glenthøj A, Glenthøj AJ, Borregaard N. ProHNPs are the principal a-defensins of human plasma. Eur J Clin Invest 2013; 43(8): 836-843.
14. Date Y, Nakazato M, Shiomi K, Toshimori H, Kangawa K, Matsuo H et al. Localization of human neutrophil peptide (HNP) and its messenger RNA in neutrophil series. Ann Hematol 1994; 69: 73-77.
15. Dancey JT, Deubelbeiss KA, Harker LA, Finch CA. Neutrophil kinetics in man. J Clin Invest 1976; 58: 705-715.
16. Price TH, Chatta GS, Dale DC. Effect of recombinant granulocyte colonystimulating factor on neutrophil kinetics in normal young and elderly humans. Blood 1996; 88: 335-340.
17. Kjeldsen L, Koch C, Arnljots K, Borregaard N. Characterization of two ELISAs for NGAL, a newly described lipocalin in human neutrophils. J Immunol Methods 1996; 198: 155-164.
18. Bayer EA, Wilchek M. Protein biotinylation. Methods Enzymol 1990; 184: 138-160.
19. Rørvig S, Honore C, Larsson L-I, Ohlsson S, Pedersen CC, Jacobsen LC et al. Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP. J Leukoc Biol 2009; 86: 1439-1449.
20. Borregaard N, Kjeldsen L, Sengeløv H, Diamond MS, Springer TA, Anderson HC et al. Changes in subcellular localization and surface expression of L-selectin, alkaline phosphatase, and Mac-1 in human neutrophils during stimulation with inflammatory mediators. J Leukoc Biol 1994; 56: 80-87.
21. Lollike K, Kjeldsen L, Sengeløv H, Borregaard N. Purification of lysozyme from human neutrophils, and development of an ELISA for quantification in cells and plasma. Leukemia 1995; 9: 206-209.
22. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 2005; 365: 1231-1238.
23. Mishra J, Ma Q, Kelly C, Mitsnefes M, Mori K, Barasch J et al. Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 2006; 21: 856-863.
24. Porstmann B, Jung K, Schmechta H, Evers U, Pergande M, Porstmann T et al. Measurement of lysozyme in human body fluids: comparison of various enzyme immunoassay techniques and their diagnostic application. Clin Biochem 1989; 22: 349-355.
25. Theilgaard-Mönch K, Jacobsen LC, Borup R, Rasmussen T, Bjerregaard MD, Nielsen FC et al. The transcriptional program of terminal granulocytic differentiation. Blood 2005; 105: 1785-1796.
26. Resnitzky P, Shaft D. Distinct lysozyme content in different subtypes of acute myeloid leukaemic cells: an ultrastructural immunogold study. Br J Haematol 1994; 88: 357-363.
27. Oberg G, Simonsson B, Smedmyr B, Tötterman TH, Venge P. Myeloid regeneration after bone-marrow transplantation monitored by serum measurements of myeloperoxidase, lysozyme and lactoferrin. Eur J Haematol 1987; 38: 356-362.
28. Lollike K, Kjeldsen L, Sengeløv H, Borregaard N. Lysozyme in human neutrophils and plasma. A parameter of myelopoietic activity. Leukemia 1995; 9: 159-164.
29. Friedl A, Stoesz SP, Buckley P, Gould MN. Neutrophil gelatinase- associated lipocalin in normal and neoplastic human tissues. Cell type-specific pattern of expression. Histochem J 1999; 31: 433-441.
30. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004; 101: 6062-6067.
31. Keshav S, Chung P, Milon G, Gordon S. Lysozyme is an inducible marker of macrophage activation in murine tissues as demonstrated by in situ hybridization. J Exp Med 1991; 174: 1049-1058.
32. Hansson M, Olsson I, Nauseef WM. Biosynthesis, processing, and sorting of human myeloperoxidase. Arch Biochem Biophys 2006; 445: 214-224.
33. Lord BI, Molineux G, Pojda Z, Souza LM, Mermod JJ, Dexter TM. Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colonystimulating factor (CSF), or granulocyte-macrophage CSF in vivo. Blood 1991; 77: 2154-2159.